Diffusion Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
Diffusion Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements https://www.diffusionpharma.com/wp-content/uploads/2020/08/AdobeStock_276012266-scaled.jpeg 2560 1707 Diffusion Pharmaceuticals Inc. https://www.diffusionpharma.com/wp-content/uploads/2020/08/AdobeStock_276012266-scaled.jpegCHARLOTTESVILLE, Va., May 04, 2022 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.